Accenture plc

(New York Stock Exchange)
Bullish +65

Boston Trust Walden Corp Sells 19,742 Shares of Accenture PLC $ACN

πŸ“‰ Boston Trust Walden Corp reduced its Accenture stake by 4.7% in Q1, selling 19,742 shares while retaining 401,133 shares valued at $79.5 million.

πŸ“ˆ Multiple institutional investors including Triumph Capital Management and the Board of the Pension Protection Fund initiated new positions in Accenture during Q3 and Q4.

πŸ’° CEO Atsushi Egawa sold 4,872 shares under a pre-arranged Rule 10b5-1 trading plan for $863,026.08, reducing his personal holding by 27.57% to 12,802 shares.

πŸ“Š Accenture reported Q2 earnings of $3.80 EPS, beating the consensus estimate of $3.70, with revenue reaching $18.72 billion.

πŸš€ Revenue grew 5.6% year-over-year to $18.72 billion, though it slightly missed the analyst consensus forecast of $18.78 billion.

πŸ’΅ The company achieved a return on equity of 26.47% and maintained a net margin of 10.66% during the quarter.

πŸ”„ Management approved a new share repurchase plan authorizing the buyback of up to $2.0 billion in shares.

πŸ’Έ Accenture declared a quarterly dividend of $1.63 per share with an ex-dividend date of July 9th and a payment date of August 14th.

πŸ“‰ The stock trades at a P/E ratio of 10.97 with a market capitalization of $91.76 billion and a beta of 1.14.

πŸ† Analysts forecast FY 2026 earnings of 13.85 EPS, aligning closely with the company's guidance range of 13.78-13.90 EPS.

Bullish Signals
  • Accenture beat quarterly earnings expectations with $3.80 EPS compared to the consensus estimate of $3.70.
  • The company demonstrated strong profitability with a return on equity of 26.47% and a net margin of 10.66%.
  • Revenue grew by 5.6% year-over-year to reach $18.72 billion, indicating continued business expansion.
  • Management initiated a $2.0 billion share repurchase program, signaling confidence in the stock's valuation.
  • The company offers an attractive dividend yield of 4.7% with a sustainable payout ratio of 52.08%.
  • Institutional interest remains robust with new positions opened by Triumph Capital Management and the Board of the Pension Protection Fund.
Risk Factors
  • Accenture's quarterly revenue of $18.72 billion slightly missed the analyst consensus estimate of $18.78 billion.
  • CEO Atsushi Egawa reduced his personal stock holdings by 27.57% through a significant sale of nearly half a million dollars worth of shares.
Full Analysis
Boston Trust Walden Corp reduced its stake in Accenture PLC (NYSE:ACN) by 4.7% during the first quarter, selling 19,742 shares to hold a remaining position of 401,133 shares valued at approximately $79.5 million. While Boston Trust decreased its holdings, several other institutional investors including Triumph Capital Management and the Board of the Pension Protection Fund established new positions in the stock during the third and fourth quarters. Accenture reported strong financial performance for the quarter ended June 18th, posting earnings per share of $3.80 which beat analyst consensus estimates of $3.70. The company generated revenue of $18.72 billion, slightly missing the consensus estimate of $18.78 billion, but achieved a year-over-year revenue growth of 5.6%. Key financial metrics include a return on equity of 26.47% and a net margin of 10.66%, with the stock trading at a P/E ratio of 10.97. The company announced significant capital return initiatives, including a Board-approved share repurchase plan authorizing the purchase of up to $2.0 billion in shares, representing 2.4% of its outstanding equity. Additionally, Accenture declared a quarterly dividend of $1.63 per share payable on August 14th for shareholders of record on July 9th, resulting in an annualized yield of 4.7% and a payout ratio of 52.08%.